Prevalence and predictors of sustained remission/low disease activity after discontinuation of induction or maintenance treatment with tumor necrosis factor inhibitors in rheumatoid arthritis: a systematic and scoping review

被引：0
|
作者：
Michael M. Ward
Nima Madanchi
Ali Yazdanyar
Nehal R. Shah
Florina Constantinescu
机构：
[1] National Institute of Arthritis and Musculoskeletal and Skin Diseases,Intramural Research Program
[2] National Institutes of Health,Division of Rheumatology, Allergy, and Immunology, Department of Internal Medicine
[3] Virginia Commonwealth University,Current address: Division of Rheumatology
[4] Johns Hopkins University School of Medicine,Department of Emergency and Hospital Medicine
[5] Lehigh Valley Hospital-Cedar Crest,Morsani College of Medicine
[6] University of South Florida,Current address: Division of Hospital Medicine
[7] University of Pennsylvania Perelman School of Medicine,Division of Rheumatology
[8] MedStar Washington Hospital Center,undefined
来源：
Arthritis Research & Therapy | / 25卷
关键词：
Rheumatoid arthritis; Tumor necrosis factor inhibitor; Remission;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Management of Perioperative Tumor Necrosis Factor α Inhibitors in Rheumatoid Arthritis Undergoing Arthroplasty: A Systematic Review and Meta-Analysis
    Goodman, Susan M.
    Menon, Indu
    Smethurst, Rie
    Christos, Paul
    Bykerk, Vivian P.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1032 - S1032
  • [32] Systematic Review of Economic Evaluations of Cycling Versus Swapping Medications in Patients With Rheumatoid Arthritis After Failure to Respond to Tumor Necrosis Factor Inhibitors
    Karpes Matusevich, Aliza R.
    Suarez-Almazor, Maria E.
    Cantor, Scott B.
    Lal, Lincy S.
    Swint, J. Michael
    Lopez-Olivo, Maria A.
    [J]. ARTHRITIS CARE & RESEARCH, 2020, 72 (03) : 343 - 352
  • [33] Efficacy of add-on tacrolimus on methotrexate to maintain clinical remission after rediscontinuation of a tumor necrosis factor inhibitor in rheumatoid arthritis patients who relapsed shortly after discontinuation of the same tumor necrosis factor inhibitor due to clinical remission
    Naniwa, Taio
    Iwagaitsu, Shiho
    Kajiura, Mikiko
    [J]. MODERN RHEUMATOLOGY, 2017, 27 (01) : 29 - 34
  • [34] Association of tumour necrosis factor a, b and c microsatellite polymorphisms with clinical disease activity and induction of remission in early rheumatoid arthritis
    Laivoranta-Nyman, S.
    Mottonen, T.
    Hannonen, P.
    Korpela, M.
    Kautlainen, H.
    Leirisalo-Repo, M.
    Julkunen, H.
    Luukkainen, R.
    Hakala, M.
    Vuori, K.
    Laine, A. P.
    Toivanen, A.
    Ilonen, J.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2006, 24 (06) : 636 - 642
  • [35] Residual symptoms and disease burden among patients with rheumatoid arthritis in remission or low disease activity: a systematic literature review
    Ishida, Masato
    Kuroiwa, Yuki
    Yoshida, Emiko
    Sato, Masayo
    Krupa, Dominika
    Henry, Nathaniel
    Ikeda, Kei
    Kaneko, Yuko
    [J]. MODERN RHEUMATOLOGY, 2018, 28 (05) : 789 - 799
  • [36] PREVALENCE OF LEUKOPENIA IN PATIENTS WITH RHEUMATOID ARTHRITIS UNDER TREATMENT WITH TUMOR NECROSIS FACTOR ALPHA INHIBITORS AND STUDY OF ITS ASSOCIATED VARIABLES
    Macias Oviedo, Leonela Lysseth
    Fornaro, Marina
    Luna, Gisele
    Schneeberger, Emilce
    Perez Alamino, Rodolfo
    Buschiazzo, Emilio
    Citera, Gustavo
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S45 - S45
  • [37] Treatment discontinuation in patients with very early rheumatoid arthritis in sustained simplified disease activity index remission after synthetic disease-modifying anti-rheumatic drug administration
    Kita, Junko
    Tamai, Mami
    Arima, Kazuhiko
    Nakashima, Yoshikazu
    Suzuki, Takahisa
    Kawashiri, Shin-ya
    Iwamoto, Naoki
    Okada, Akitomo
    Koga, Tomohiro
    Yamasaki, Satoshi
    Nakamura, Hideki
    Origuchi, Tomoki
    Ida, Hiroaki
    Aoyagi, Kiyoshi
    Uetani, Masataka
    Eguchi, Katsumi
    Kawakami, Atsushi
    [J]. MODERN RHEUMATOLOGY, 2012, 22 (03) : 346 - 352
  • [38] Insulin-Sensiting Effects of Tumor Necrosis Factor Alpha Inhibitors in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
    Leporini, Christian
    Russo, Emilio
    D'Angelo, Salvatore
    Arturi, Franco
    Tripepi, Giovanni
    Peluso, Rosario
    Grembiale, Rosa Daniela
    Olivieri, Ignazio
    De Sarro, Giovambattista
    Ursini, Francesco
    [J]. REVIEWS ON RECENT CLINICAL TRIALS, 2018, 13 (03) : 184 - 191
  • [39] Cost-utility analysis of treatment options after initial tumor necrosis factor inhibitor therapy discontinuation in patients with rheumatoid arthritis
    Matusevich, Aliza R. Karpes
    Lai, Lincy S.
    Chan, Wenyaw
    Swint, J. Michael
    Cantor, Scott B.
    Suarez-Almazor, Maria E.
    Lopez-Olivo, Maria A.
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021, 27 (01): : 73 - 83
  • [40] Down-titration and discontinuation strategies of tumour necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity
    Verhoef, Lise M.
    van den Bemt, Bart J. F.
    van der Maas, Aatke
    Vriezekolk, Johanna E.
    Hulscher, Marlies E.
    van den Hoogen, Frank H. J.
    Jacobs, Wilco C. H.
    van Herwaarden, Noortje
    den Broeder, Alfons A.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (05):
12345